Spinach salads and almond butter sound like the healthiest choices on any menu, but new research says the oxalate hiding inside them may be quietly fueling gut inflammation in people with Crohn’s disease and ulcerative colitis.
Quick Take
- A University of North Carolina (UNC) study finds two gut proteins that clear oxalate are consistently reduced in patients with inflammatory bowel disease (IBD).
- Without those transporters working right, oxalate from foods like spinach, almonds, beets, and cocoa can build up in the intestines.
- Researchers say the buildup may worsen inflammation, especially in genetically susceptible patients, even at moderate intake.
- UNC stresses this is not a call to cut plant foods entirely, and no human trial yet proves oxalate reduction eases symptoms.
What The New Study Actually Found
Researchers at UNC discovered that two transporter proteins, SLC26A2 and SLC26A3, show up at lower levels in gut tissue from IBD patients. This pattern held true across Crohn’s disease and ulcerative colitis, in both the colon and the ileum, and regardless of whether inflammation was active at the time of testing. That consistency is what makes the finding stand out from earlier, scattered observations.
Those transporters normally help the body handle oxalate, a compound found naturally in many plant foods. When the transporters do not work properly, oxalate is not absorbed the way it should be. Instead, it stays behind in the intestinal environment, and the study’s data suggest it adds fuel to the same inflammation that drives IBD symptoms. The published journal abstract goes further, stating dietary oxalate may exacerbate innate immune responses in people who are already genetically susceptible.
Why Scientists Call This A Real Biological Signal
This is not a one-off lab quirk. The transporter reduction showed up across disease subtypes, across tissue sites, and in mouse models of colitis regardless of what diet the mice were fed. That kind of repeated pattern across different conditions is exactly what researchers look for before treating a finding as biologically meaningful rather than a fluke of one small sample.
The paper’s authors describe altered oxalate handling as a potential contributor to how IBD develops and worsens, not a minor side detail. UNC also says this is the first study to use DNA-based diet tracking, called metabarcoding, in IBD patients while linking impaired oxalate handling directly to how severe their disease becomes. Older research backs up part of this picture too, showing Crohn’s patients have long had higher oxalate levels in their urine than healthy people, especially those with ileal disease.
What The Evidence Does Not Yet Prove
Here is where a skeptical reader should slow down. The study’s own language says oxalate “may exacerbate” inflammation, which is scientific shorthand for a strong association, not proof of cause and effect. No published trial has yet put patients on a low-oxalate diet and measured whether their flares, hospital visits, or colonoscopy results actually improve.
There is also a chicken-and-egg problem. Because transporter levels drop whether or not inflammation is active, it is possible that intestinal damage causes the transporter loss, rather than the transporter loss causing the damage. Sorting out which comes first will take follow-up studies that track patients over time, not just a single snapshot of tissue.
Why Doctors Are Not Rewriting Diet Plans Yet
Major nutrition guidelines have not budged. The European Society for Clinical Nutrition and Metabolism says oxalate restriction is warranted mainly for patients with recurring kidney stones, not IBD inflammation broadly. The European Crohn’s and Colitis Organisation echoes that, listing a low-oxalate diet as a kidney-stone prevention tool, while still allowing many fruits and vegetables on the plan. That is a far cry from telling every IBD patient to avoid spinach.
UNC’s own team makes the same point. Their release states plainly that the findings do not call for eliminating plant foods from the IBD diet, and that patients can keep a nutritionally complete, plant-based pattern while trimming total oxalate intake. For readers wary of trendy diet panics, that caution is the responsible read: real biology worth investigating, not an excuse for blanket food bans pushed before the science is settled.
What Comes Next For Patients And Researchers
The honest next step is a randomized trial testing a low-oxalate diet against a normal one, tracking inflammation markers and symptoms directly in Crohn’s and ulcerative colitis patients. Until that data exists, this remains a promising lead rather than a treatment plan. Patients curious about their own oxalate intake should talk to their gastroenterologist before cutting foods like almonds or beets, since those foods still carry real nutritional value.
A hidden compound in healthy foods may worsen IBD | The University of North Carolina at Chapel Hill
Spinach, almonds, and sweet potatoes are often praised for their nutritional value. But new research from the UNC School of Medicine suggests that for people with inflammatory… pic.twitter.com/u0IvnBdFm5
— Owen Gregorian (@OwenGregorian) September 13, 2026
A single study, however well designed, is a starting point, not a verdict. This one deserves attention and follow-up funding, not headlines telling people to fear their vegetables overnight.
Sources:
sciencedaily.com, news.unchealthcare.org, pubmed.ncbi.nlm.nih.gov, it-boltwise.de, pmc.ncbi.nlm.nih.gov
